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Mycoplasma pneumoniae is a common cause of respiratory tract infections (RTIs) in
children. We recently demonstrated that this bacterium can be carried asymptomatically
in the respiratory tract of children. To identify potential genetic differences between
M. pneumoniae strains that are carried asymptomatically and those that cause
symptomatic infections, we performed whole-genome sequence analysis of 20
M. pneumoniae strains. The analyzed strains included 3 reference strains, 3 strains
isolated from asymptomatic children, 13 strains isolated from clinically well-defined
patients suffering from an upper (n = 4) or lower (n = 9) RTI, and one strain isolated
from a follow-up patient who recently recovered from an RTI. The obtained sequences
were each compared to the sequences of the reference strains. To find differences
between strains isolated from asymptomatic and symptomatic individuals, a variant
comparison was performed between the different groups of strains. Irrespective of
the group (asymptomatic vs. symptomatic) from which the strains originated, subtype
1 and subtype 2 strains formed separate clusters. We could not identify a specific
genotype associated withM. pneumoniae virulence. However, we found marked genetic
differences between clinical isolates and the reference strains, which indicated that
the latter strains may not be regarded as appropriate representatives of circulating
M. pneumoniae strains.
Keywords: Mycoplasma pneumoniae, whole genome sequencing, infection, colonization, respiratory tract
infections
INTRODUCTION
Mycoplasma pneumoniae is a human bacterial pathogen that has been estimated to cause
pneumonia in up to 40% of children hospitalized because of community-acquired pneumonia
(Waites and Talkington, 2004). In addition, M. pneumoniae is associated with extra-
pulmonary manifestations of which the most common are central nervous system complications
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(e.g., Guillain-Barré Syndrome and encephalitis), haemolytic
anemia, non-specific myalgias or arthralgias, and renal
complications, such as glomerulonephritis. M. pneumoniae
infections are commonly treated with antibiotics that
target the bacterial DNA metabolism or protein synthesis.
However, evidence for effectiveness of these antibiotics against
M. pneumoniae infections is scarce and based on comparative
studies (Mulholland et al., 2012).
A recent study has shown that M. pneumoniae can also be
carried asymptomatically: the bacterium was detected in the
upper respiratory tract of 21% of children that did not show
any signs of a respiratory tract infection (RTI) (Spuesens et al.,
2013). Asymptomatic carriage of potential pathogens is a well-
known, common phenomenon in the general population. For
instance, potential pathogens like Streptococcus pneumoniae,
Staphylococcus aureus and rhinovirus can cause RTIs, but
can also be carried asymptomatically. Clearly, it is important
to identify the determining factors, both from pathogen and
host, involved either in control of an asymptomatic carriage
status or in triggering symptomatic infection. In the case of S.
pneumoniae, specific bacterial gene clusters were found to be
associated with invasive disease (Wulff-Burchfield et al., 2010).
Several M. pneumoniae virulence factors have been identified
in previous studies (Waites and Talkington, 2004). The first
step to invasive disease is the attachment of M. pneumoniae to
its human host using an elaborate attachment organelle, which
consists of several attachment and accessory proteins. Without
an intact attachment organelle, M. pneumoniae is unable to
cause disease. Several other virulence mechanisms include direct
cytotoxicity (e.g., by production of H2O2) and activation of
the inflammatory cascade leading to cytokine-mediated tissue
injury (Waites and Talkington, 2004). In 2005, the Community-
Acquired Respiratory Distress Syndrome (CARDS) toxin was
discovered as another potential virulence factor (Kannan et al.,
2011). It is unknown whether all M. pneumoniae strains express
these factors or whether there are genes in M. pneumoniae
associated with carriage and/or pathogenicity.
Until a few years ago, only a single genome sequence was
available for M. pneumonia (Himmelreich et al., 1996). This
sequence was derived from laboratory strain M129. Since 2013,
several other genomic sequences have been published (Lluch-
Senar et al., 2015; Simmons et al., 2013; Xiao et al., 2015). Most of
these sequences were obtained in two independent studies. One
of these studies reported the comparative genome analysis of 15
M. pneumoniae strains isolated form respiratory tract samples
and cerebrospinal fluid samples collected from patients between
1940 and 2009 in the USA, China, and England (Xiao et al.,
2015). The other study reported the sequences of 23 clinical
M. pneumoniae strains isolated between 1964 and 2011 in six
different countries (Lluch-Senar et al., 2015). In both studies,
the genomes of M. pneumoniae strains seem very stable over
time and at different locations in the world. The sequences of
these studies show a low number of non-synonymous single-
nucleotide polymorphisms, but a high rate of variation among
repetitive elements (Lluch-Senar et al., 2015; Xiao et al., 2015).
Despite the availability of a significant set of M. pneumoniae
genome sequences, it is currently difficult to determine the
association betweenM. pneumoniae genotype and virulence. This
is mainly due to the fact that all knownM. pneumoniae sequences
were exclusively obtained from strains isolated from patients
with RTI symptoms. Clearly, this precludes determination of the
putative genetic differences between strains causing symptomatic
infections and strains carried by asymptomatic individuals.
The recent isolation of a set of M. pneumoniae strains from
both asymptomatic children and children suffering from RTI
(Spuesens et al., 2013), however, allows a direct comparison of
the genetic make-up of strains associated with bacterial carriage
and those involved in symptomatic infection. We therefore set
out to determine the genome sequence of 3 reference strains
(M129, FH, and R003), 3 strains from asymptomatic individuals,
and 13 strains from clinically well-defined patients suffering from
either an upper or lower RTI. The analysis and comparison of the
obtained sequences did not reveal a specific genotype associated
with M. pneumoniae virulence. However, we did find striking
differences between the genomes of clinical isolates and those of
theM. pneumoniae reference strains.
METHODS AND MATERIALS
Patient Samples
Most of the patient samples were collected as part of a clinical
study designed to investigate the existence of M. pneumoniae
asymptomatic carriage in children (Spuesens et al., 2013).
This study was carried out in Rotterdam, the Netherlands
between 2008 and 2012. Patient information was collected
and documented prospectively as part of the study. All
M. pneumoniae culture-positive samples from the different
groups (asymptomatic, symptomatic, and follow-up) were
selected for analysis as part of this study. The other samples from
symptomatic patients were collected by the Regional Laboratory
of Public Health Kennemerland, Haarlem, The Netherlands.
These samples were taken from patients with suspected M.
pneumoniae infection as part of the medical work-up ordered by
the treating physician. All samples with a positive culture for M.
pneumoniae were selected and used in this study. The Medical
Ethics Review Board of the Erasmus MC approved the study on
asymptomatic carriage (NL20418.078.08) and written informed
consent was obtained in this study from all parents and children
above the age of 12 years. TheMedical Ethics Review Board of the
Erasmus MC approved the use of the samples collected during
routine medical work-up in the Regional Laboratory of Public
Health Kennemerland (MEC 2013-344).
Culture and DNA Isolation
The culturing of M. pneumoniae was performed in the
laboratory of pediatrics of the Erasmus MC, as previously
described (Sluijter et al., 2008). In short, 100 µl original sample
and 10-fold dilutions were used for culturing. Culturing was
performed in Mycoplasma medium containing 1.4% DifcoTM
PPLO broth (Becton Dickinson), 0.15% DifcoTM TC Yeastolate,
UF (Becton Dickinson), 1.4% glucose, 20% horse serum,
1,000U/ml Penicillin G, 500U/ml Polymyxine B, and 0.02mg/ml
phenol red. The pH of the medium was adjusted to 7.8–8.0 using
a solution of 2NNaOH, followed by filter-sterilization. Cells were
harvested upon color change of the medium (from red/orange
to yellow). The cells were added to Mycoplasma medium agar
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plates and single colonies were harvested. These were grown
in 3 ml of medium at 37◦C/5% CO2 in 25 cm
2 tissue culture
flasks (Greiner). Cells were harvested upon color change of the
medium, and DNA was isolated from the cells as described
previously (Spuesens et al., 2009).
Grouping of the Strains
The strains were divided into 4 groups as indicated in Table 1.
Group 1 includes reference strains M. pneumoniae M129
(subtype 1, ATCC 29342),M. pneumoniae FH (subtype 2, ATCC
15531) andM. pneumoniae R003 (subtype 2a). The other groups
consisted of strains isolated from asymptomatic children (Group
2), patients with an upper RTI (Group 3) and patients with a
lower RTI (Group 4).
Sequencing
The sequencing of all strains including re-sequencing of the
reference strains was performed at the Center for Biomics
of the Erasmus MC using an Illumina HiSeq2000 sequencer.
DNA libraries were prepared according to the Illumina TruSeq
DNA protocol. The libraries were sequenced using the TruSeq
V2 protocol with paired-end 100-bp reads. Between 0.9 and
2.5 gigabases of DNA sequence was generated for each of
the isolates and a 1224- to 3300-fold genome coverage was
obtained. The generated short-read datasets were submitted to
the NCBI Sequence Read Archive (SRA) under accession number
SRP081446.
De novo Assembly
To check the quality of the raw sequence data we used FastQC.
This analysis showed that the majority of the sequenced data had
a PHRED quality score exceeding Q30, which is considered as
good quality (Supplementary File 1). Reads were purged from
the Illumina sequence adapter and renamed according to the
standards expected by Abyss (Software Abyss 1.3.6). Bases with
a PHRED quality score below 30 (base call accuracy ≥ 99.9%)
were not used in the assembly. After the initial processing, Abyss
was run for each of the samples individually. For each sample, the
optimal k-mer was determined by varying k between 25 and 100
in steps of 5 (Supplementary Figure 1). The assembly with the
largest N50 contig was considered optimal.
The assembled sequences were separately reported by Abyss as
unitigs, contigs, and scaffolds. The unitig files hold the assemblies
that were generated without taking the pair information into
account. The contigs are the assemblies generated with the pair
information taken into account. Scaffolds consist of merged
contigs based on read pairs, and differ from the contigs in
that they may contain unresolved repeats and spacers. For the
TABLE 1 | Sample ID, patient information, strain information and de novo assembly information.
Group Strain/sample ID Diagnose group Sequence ID Size (bp)b Subtypec Largest contig (bp) N50 contig (bp) M129 genome
covered (%)d
1 M129 Reference 01 802,479 1 135,172 59,602 99.89
FH Reference 02 803,911 2 98,770 50,959 99.29
R003 Reference 03 800,612 2 123,538 54,253 99.21
2 B174 Asymptomatic 11 805,944 1 135,177 53,512 99.83
B247 Asymptomatic 12 801,799 1 96,961 66,934 99.63
B406 Asymptomatic 14 804,626 2 98,962 51,557 99.06
3 A016 Upper RTI 04 800,489 2 123,550 54,265 99.18
A058 Upper RTI 06 800,399 1 135,171 54,703 99.73
C024 Upper RTI 15 809,160 1 135,170 59,355 99.85
H030 Upper RTI 19 806,820 1 135,258 59,621 99.81
4 A035 Lower RTI 05 805,945 2 123,540 54,255 99.04
A103 Lower RTI 07 821,841 1 92,532 45,886 99.73
HAP111 Lower RTI 10 808,319 2 135,217 54,427 99.23
HAP157 Lower RTI 09 800,436 1 92,731 51,728 99.73
H010 Lower RTI 18 805,135 1 191,508 66,444 99.67
H016 Lower RTI 20 805,824 1 135,161 59,300 99.77
H026 Lower RTI 13 790,390 2 98,587 48,754 98.80
C036-1a Lower RTI 16 807,258 1 135,171 59,440 99.77
C036-2a Lower RTI 17 804,586 1 191,498 66,641 99.73
HAP157FUP Follow-up 08 802,814 1 191,496 66,615 99.75
aMorphologically different M. pneumoniae colonies originating from the same patient sample. Both a large (C036-1) and a small colony (C036-2) were sequenced.
bTotal assembly (bp). Contigs over 500 bp in length are considered in the assembly size.
cSubtype 1 and 2 as described previously by Spuesens et al. (2013).
dAll contigs, including contigs below 500 bp in length, were aligned to the M129 reference genome with MUMmer.
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downstream analysis, the contigs from the assemblies with the
largest N50 contigs were used. These contigs are presented in
Supplementary File 3.
Larger rearrangements, insertions and deletions were
determined by comparing the assembled contigs with the
M. pneumoniae M129 reference genome (NCBI accession
number NC_000912.1). This alignment was performed
with MUMmer (version 3.23) (Kurtz et al., 2004). These
alignments are presented in Supplementary File 2. Analysis of
the alignments was performed in R (version 3.2.2).
SNV and InDel Comparisons
In addition to the de novo assembly, the reads were aligned to
the M. pneumoniae M129 reference genome (NCBI accession
number NC_000912.1) using BWA (Li and Durbin, 2009)
(version 0.5.9) to detect smaller variants. Single-nucleotide
variants (SNVs) and short insertions and deletions (InDels)
were determined relative to the reference strain with SAMtools
mpileup (Li et al., 2009) (version 0.1.16) (Supplementary Table 1
and Supplementary File 4). For each sample, the frequencies of
the SNVs and InDels relative to the total number of reads at that
position were determined as well.
The strains were clustered based on their SNV/InDel profiles.
SNV/InDels that were not present in at least 20% of the reads at a
position in a single strain were removed from the analysis. These
filtered SNV/InDels were considered low-abundant and may be
caused by intrastrain variations or technical errors. The strains
were then clustered based on their SNV/InDels profiles using
hierarchical clustering. The distances between the SNV/InDels
profiles were calculated with the Euclidean distance measure.
These analyses were performed with standard facilities present
in R (version 3.2.2) (Kurtz et al., 2004; Wickham, 2009; R
Development Core Team, 2011; de Vries and Ripley, 2015).
RESULTS
Selection of Strains and Isolates of
M. pneumoniae
We have determined the complete genome sequences of a total
of 20 strains or isolates of M. pneumoniae. The isolates were
obtained either from asymptomatic children (n = 3), from
patients with an upper RTI (URTI; n = 4), or from patients
with a lower RTI (LRTI; n = 9). The names (ID) and origins
of the isolates are listed in Table 1. Two of the isolates from
the LRTI group were obtained at the same time from a single
patient (C036-1 and C036-2). These two isolates were selected
because they differed in colony morphology on agar plates. Two
other samples from the LRTI group were also collected from a
single patient, one at the moment of RTI (HAP157) and one
collected 4 weeks later, after recovery of the clinical symptoms
(HAP157FUP). In addition to the clinical isolates, three reference
laboratory strains were included in this study, i.e., subtype 1
strain M129, and subtype 2 strains FH and R003.
DNA Sequencing and de novo Genome
Sequence Assembly
The genomic sequences of the 20 M. pneumoniae strains were
determined using a paired-end 100-bp sequencing protocol on
the HiSeq2000 platform (Illumina). For each of the strains,
genome assemblies were generated that ranged from 790 kb
(H026) to 821 kb (A103) in length (Table 1). These cumulative
contig lengths are similar to the published genome length of
reference strain M129 (816 kb) (Himmelreich et al., 1996). For
strain M129, which was also included in our study, the total
amount of sequence contained in contigs over 500 bp was found
to be ∼802 kb, which is 14 kb shorter than the previously
published genome size of this strain (Table 1). Thus, ∼2% of the
M129 genome could not be reliably retrieved with the procedures
used in this study. When contigs under 500 bp were considered
as well, 99.9% of the M129 genome was covered (Table 1;
Supplementary Table 1). The gaps are likely caused by repetitive
sequences (RepMP sequences) (Spuesens et al., 2009) in the
genome ofM. pneumoniae,which are known to pose problems in
short read sequencing. Gaps similar to those in theM129 genome
were also found in the other strains (Table 1). Strikingly, the type
1 strains covered∼0.5% of the M129 genome more than the type
2 strains did. This difference is centered around a single locus at
position 558,624–561,515, which is present in type 1 strains but
is absent from type 2 strains (Supplementary File 2).
We identified one sequence stretch within the assembled
contigs that was exclusively present in type 2 strains. The length
of this stretch is 5.3 kb (in strains R003, A016, and A035) or 5.7 kb
(in strains FH, B406, HAP111, and H026). The 5.3-kb fragment
completely overlaps with the 5.7-kb fragment and corresponds to
the sequence at position 704,213–709,505 of the FH genome. The
5.7-kb fragment corresponds to position 703,813–709,505 of this
genome.
Sequence Differences between Strains
Isolated from Asymptomatic and
Symptomatic Individuals
To compare the genomic sequences of the different
M. pneumoniae strains, their SNV/InDels profiles were subjected
to hierarchical clustering analysis (Figure 1). This analysis clearly
distinguished two major families of strains, which correspond
to the known major subtypes of M. pneumoniae, i.e., subtypes
1 and 2. However, genetically similar strains did not cluster
together with regard to the clinical groups of patients they were
isolated from (Groups 1–4 in Table 1). For example, strain B406,
which was isolated form an asymptomatic child (Group 2),
shows a high degree of similarity with strain H026, which was
isolated from an adult with an LRTI (Group 4). The hierarchical
clustering based on SNV/InDels therefore does not indicate that
the overall genome similarity is greater among the strains within
each group than between strains from different groups.
To investigate whether the strains within each of the
four groups share specific single nucleotide polymorphisms,
small insertions or deletions in their genomes, a subtractive
comparative approach was performed in which the following
criteria were applied: (1) all variants with a low coverage (less
than 21 times covered sequence) are filtered in each sample,
(2) SNV/InDels present in the asymptomatic group are filtered
from those in the other groups except the reference group
(since SNV/InDels in the asymptomatic group are unlikely
to cause a “phenotype”), (3) all SNV/InDels present in the
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FIGURE 1 | Hierarchical clustering based on Euclidean distance. The Euclidean distance between variant frequencies (on the y-axis) is plotted against the
different strains sequenced in this study. The strains are indicated by their sequence ID listed in Table 1. Only the variants with a frequency above 0.2 were used in this
analysis (see the text for details). Hierarchical clustering was applied based on Euclidean distance and the average linkage method (hclust).
reference group are filtered from those in the other groups
except the asymptomatic group, and (4) only SNV/InDels are
analyzed that are present in all samples in one group. Using this
procedure, we were unable to identify variants that were shared
between all samples from the same group. Although a number of
variants were shared between some samples from the same group
(Table 2), we did not find specific sequence differences between
the strains from the group of symptomatic patients (Groups
3 and 4) and those from the other groups (Groups 1 and 2).
Variant frequencies for the different comparisons are shown in
Tables 2–4.
Variation in Follow-Up Samples of a Single
Patient
Two of the isolates that were sequenced were acquired at
two different time-points from the same patient. The first
isolate, HAP157, was obtained when this patient suffered from
an LRTI. The other isolate, HAP157FUP, was taken 4 weeks
later, after resolution of the infection following a course of
antibiotics (azithromycin). Eight relevant differences were found
between strains HAP157 and HAP157FUP (Table 3). One of
these differences was localized to the P1 gene (MPN141), which
encodes the major attachment protein of M. pneumoniae; in
contrast to strain HAP157, HAP157FUP was found to have a
deletion of an AGT triplet at position 182,792–182,794 within
the P1 gene. This triplet is part of a previously described tandem
repeat of which the biological relevance is yet unknown (Dorigo-
Zetsma et al., 2001).
The Sequences of Isolates Displaying
Differences in Colony Morphology
Two of the strains (C036-1 and C036-2) were isolated from the
same patient at a single time point. These strains were analyzed
separately because they displayed different colony morphologies
on agar plates. The sequences of these strains were found to be
highly similar (Figure 1): only 5 SNPs were identified between
these strains (Table 4).
DISCUSSION
We determined the complete genome sequences of
M. pneumoniae isolates obtained from asymptomatic M.
pneumoniae carriers, and from patients suffering from an
upper or lower RTI caused by M. pneumoniae. In addition, we
analyzed the genomes of 3 M. pneumoniae reference strains. In
a comparison of these sequences, we could not identify a specific
genotype that is associated with M. pneumoniae virulence or
asymptomatic bacterial carriage.
Our previous findings on sequence variation among
M. pneumoniae strains, which mainly focussed on the P1
gene and repetitive elements (RepMP sequences), showed that
variation among repetitive sequences is very common in this
bacterium (Spuesens et al., 2009, 2010). In the current analysis of
whole-genome sequences of 20 differentM. pneumoniae isolates,
however, we did not identify large genomic rearrangements.
These findings are concordant with those of Xiao et al. In their
analysis, the sequences of 15 M. pneumoniae strains seem very
stable over time and at different locations in the world. Similarly,
Lluch-Senar et al. (2015) found a relatively low number of
non-synonymous SNPs among the genome sequences of 23
strains from 6 different countries. However, they do report
a high rate of variation among repetitive elements in the M.
pneumoniae genomes (Lluch-Senar et al., 2015).
Although we were able to reliably determine the genomic
sequences ofM. pneumoniae isolates from different well-defined
groups of patients, the most important drawback of our study
is the limited availability of M. pneumoniae isolates from
asymptomatic patients. In routine microbiological diagnostics,
asymptomatic patients are usually not tested for the presence
of M. pneumoniae. In addition, in our previous study on
asymptomatic carriage ofM. pneumoniae, only a limited number
of M. pneumoniae PCR-positive samples also turned out to be
culture-positive (Spuesens et al., 2013). Clearly, for genomic
sequence analysis, culturing is a crucial step in obtaining pure,
clonal bacterial isolates. Nevertheless, in future studies, we aim to
obtain higher number of M. pneumoniae isolates from different
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TABLE 2 | SNV/InDels frequencies of the isolates from symptomatic groups.
Upper RTI group
SNV/InDels Sequence ID Locus
(NC_000912.1) 05 07 09 10
111954-111954:C-A 0.28 0.00 0.24 0.20 MPN089
528806-528806:G-GT 0.38 0.42 0.33 0.05 NA
536132-536132:A-ACC 0.67 0.00 0.00 0.71 MPN442
622601-622601:G-GTT 0.38 0.40 0.10 0.33 NA
706408-706408:A-ACC 0.21 0.01 0.00 0.22 NA
Lower RTI group
SNV/InDels Sequence ID Locus
(NC_000912.1) 05 07 09 10 13 16 17 18 20
41006-41006:G-A 0.00 0.00 0.00 0.00 0.00 0.99 1.00 1.00 0.00 MPN034
140960-140960:C-A 0.00 0.00 0.00 0.00 0.00 1.00 0.99 1.00 0.00 MPN108
171528-171528:A-AG 0.00 0.00 0.00 0.00 0.00 0.67 0.68 0.66 0.00 MPN132
171529-171529:C-CCCAAG 0.00 0.00 0.00 0.00 0.00 0.66 0.67 0.65 0.00 MPN132
405692-405692:A-T 0.00 0.00 0.00 0.00 0.00 0.99 0.99 1.00 0.00 MPN341
428005-428005:A-G 0.00 0.00 0.00 0.00 0.00 1.00 0.99 1.00 0.00 MPN358
536132-536132:A-ACC 0.68 0.00 0.00 0.01 0.00 0.73 0.70 0.71 0.67 MPN442
622601-622601:G-GTT 0.18 0.06 0.40 0.39 0.01 0.04 0.06 0.30 0.33 NA
733651-733651:G-A 0.00 0.00 0.00 0.00 0.00 0.99 0.99 1.00 0.00 MPN612
NA, Not applicable.
TABLE 3 | Variant frequencies of strains HAP157 and HAP157FUP.
SNV/InDels Sequence ID Locus
(NC_000912.1) 08 09
182792-182794:AGT- 0.66 0.01 MPN141
195459-195459:C-CA 0.25 0.04 NA
570767-570767:G-T 0.89 0.62 NA
570769-570769:A-G 0.88 0.61 NA
570770-570770:C-G 0.85 0.61 NA
622601-622601:G-GTT 0.04 0.40 NA
622601-622601:G-GT 0.41 0.14 NA
649041-649041:G-T 0.91 0.00 NA
NA, Not applicable.
groups of asymptomatic individuals. This should provide more
insight in the physiology of asymptomatic colonization of the
human respiratory tract byM. pneumoniae.
Another important issue to consider is whether or not
M. pneumoniae was the actual causative agent of the RTI in the
different groups of symptomatic patients that were included in
this study. Recent studies have indicated that multiple pathogens
can be present in the respiratory tract of children and adults
with RTI (Spuesens et al., 2013; Biesbroek et al., 2014a,b; Dickson
et al., 2014). As a consequence, we cannot rule out that pathogens
other than M. pneumoniae might have caused the symptomatic
“phenotype” in at least some of the included symptomatic
patients. Clearly, this may have obstructed the identification of
potential genomic features that allow discrimination between
TABLE 4 | Variant frequencies of the isolates C036-1 and C036-2 with
different colony morphologies.
SNV/InDels Sequence ID Locus
(NC_000912.1) 16 17
195459-195459:C-CA 0.03 0.25 NA
626378-626378:G-T 0.00 0.35 NA
649044-649044:G-C 0.99 0.00 NA
649047-649047:G-T 0.00 0.99 NA
716850-716850:C-A 0.00 0.38 MPN594
NA, Not applicable.
pathogenicM. pneumoniae strains and strains that can be carried
asymptomatically by the human host.
In conclusion, in this study we have shown that there is no
specific genotype that can be associated with M. pneumoniae
virulence or asymptomatic carriage. In addition, we found
marked genetic differences between clinical isolates and the
reference strains, which indicated that the latter strains may
not be regarded as appropriate representatives of circulating
M. pneumoniae strains.
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